Melanie L. Bell, Ph.D., from the University of Arizona in Tucson and colleagues estimated the prevalence of post-acute sequelae of COVID-19 (PASC) -- defined as experiencing at least one symptom ≥30 days – and the prevalence of individual symptoms among 303 non-hospitalized individuals with a positive lab-confirmed COVID-19 test and mild or moderate disease with follow-up for a median 61 days.

A free webinar, “Preventing Cognitive Decline at Late-Life,” will be hosted by the Institute for Mental Health Research (IMHR) September 9. Jordan Karp, MD, a member of the IMHR Scientific Advisory Council, who is an internationally-recognized geriatric psychiatrist, professor and chair of the Department of Psychiatry at the College of Medicine – Tucson, will share his research on cognitive decline.

Understanding your emotions and a willingness to adjust after months of social distancing are key to a successful return.

COVID-19 hospitalizations continue to rise in Iowa, and among the health care workers who have been vital to caring for the sickest patients are nurses. Now just about a year and a half into the pandemic, many are at risk of burning out. "We, for so long, have really shied away from making legislation about staffing, for example, and really trying to address burnout," said Jessica Rainbow, PhD, RN, an assistant professor in the College of Nursing.

A University of Arizona Cancer Center-based program fosters the next generation of Native American scientists and doctors.

A new study led by the University of Arizona College of Nursing will examine the prevalence of cannabis and other substance use in nurses who may work through significant pain and be at risk for substance abuse.

Continuing coverage: University of Arizona Health Sciences researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy is now proceeding through a Phase 2b clinical trial. Roberta Diaz Brinton, PhD, director of the UArizona Center for Innovation in Brain Science, is the lead investigator.

Researchers at the University of Arizona Health Sciences say using nanotechnology to deliver chemotherapy, could be a more effective way to fight aggressive tumors. "We found that our nano platform can not only increase effectiveness of the immunotherapy but also can activate our body's own memory immunity," said Jianqin Lu, PhD, an assistant professor of pharmaceutical sciences at the College of Pharmacy.

Mia Smitt, a recently retired nurse practitioner, writes about coccidioidomycosis, citing the the University of Arizona Valley Fever Center for Excellence as a great reference for both health care providers and the public.